Ballou 2022, NASEM 2022: the National Academy of Medicine (collaborator: US CDC/PIVI) convened a workshop focused on lessons learned from COVID-19 to inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response.
See discussion paper
See workshop proceedings
Krammer 2023 reviewed COVID-19 vaccine development during the pandemic and highlighted scientific, technological, and policy issues that need to be addressed for pandemic preparedness, including the need to provide sufficient R&D funding and to counteract vaccine hesitancy, misinformation, and anti-vax conspiracy movements.
Palache 2023 (IFPMA) summarized lessons learned for vaccine manufacturing during a pandemic (e.g., regarding pathogen surveillance and data sharing, equitable distribution, and pharmaceutical partnerships to accelerate R&D and manufacturing).
Arinaminpathy 2022 summarized lessons learned for influenza vaccine R&D from the COVID-19 pandemic in the topic areas of epidemiological implications, economic implications, global production capacity, and roles for donors and policy-makers.
Johnson 2022 (BARDA) summarized lessons learned from the development of COVID-19 vaccines, including gaps and challenges that must be addressed to prepare for future outbreaks caused by pandemic viruses.